Study Data from Inova Schar Cancer Institute Provide New Insights into Robotics [Feasibility of Patient-specific Quality Assurance (Psqa) for Real-time Robotic Stereotactic Body Radiotherapy (Sbrt) Based On Tumor Motion Traces].

Předmět:	STEREOTACTIC radiotherapy ROBOTICS QUALITY assurance TECHNOLOGICAL innovations MEDICAL physics
Zdroj:	Drug Week; 6/7/2024, p2625-2625, 1p
Abstrakt:	A study conducted by researchers at the Inova Schar Cancer Institute in Fairfax, Virginia, explored the feasibility of using patient-specific quality assurance (PSQA) for real-time robotic stereotactic body radiotherapy (SBRT) based on tumor motion traces. The study utilized the CyberKnife Synchrony system and a motion platform to evaluate dosimetric accuracy. Results showed that it may be feasible to perform PSQA for Synchrony patients with a realistic breathing pattern. This study is the first to benchmark PSQA for the CyberKnife Synchrony system using moving phantoms with rotation. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu